Successful laparoscopic management of unilateral chyluria in a 5 year old

K Senthil Ganesh1, S Rao, A J D'Cruz

  • 1Division of Pediatric Surgery, Narayana Hrudayalaya Children's Hospital, No.258/A, Bommasandra Industric Area, Anekal Taluk, Bangalore 560 099, India.

Insights

Chyluria, the abnormal passage of chyle in urine, can be successfully treated in children. Laparoscopic lymphorenal disconnection effectively managed a pediatric case resistant to conservative therapies.

Area of Science:

  • Urology
  • Pediatric Surgery
  • Tropical Medicine

Background:

  • Chyluria is the abnormal presence of chyle in urine, typically affecting adults and often caused by Wuchereria bancrofti.
  • While common causes include parasitic infections, trauma, tumors, tuberculosis, and congenital issues, pediatric cases are less frequent.
  • Unilateral chyluria in children can present as a long-standing, symptomatic, and treatment-resistant condition.

Purpose of the Study:

  • To report the successful management of a pediatric patient with unilateral chyluria.
  • To evaluate the efficacy of laparoscopic lymphorenal disconnection in a child with resistant chyluria.
  • To review the literature on chyluria management in pediatric populations.

Main Methods:

  • A case study of a 5-year-old child with symptomatic unilateral chyluria.
  • Conservative treatment modalities were attempted and failed.
  • Laparoscopic lymphorenal disconnection was performed to address the condition.

Main Results:

  • The laparoscopic lymphorenal disconnection resulted in an excellent outcome for the patient.
  • The child experienced resolution of symptoms following the surgical intervention.
  • This case highlights a viable surgical option for pediatric chyluria.

Conclusions:

  • Laparoscopic lymphorenal disconnection is an effective treatment for pediatric chyluria resistant to conservative management.
  • Early surgical intervention may be considered for persistent symptomatic cases in children.
  • Further research into pediatric chyluria is warranted to optimize treatment strategies.